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The effects of N6,d’-dibutyryladenosine 3’ : 5’-cyclic monophosphate (DBcAMP), I-bromoadenosine 
3 ’ : 5 ‘-cyclic monophosphate (8Br-CAMP), 3 ’ : 5 ’ -cyclic monophosphate (CAMP), L-isoproterenol and L- 
epinephrine on sulfated-proteoglycan sy thesis by rabbit articular chondrocytes were compared. DBcAMP 
and 8Br-CAMP in the presence or absence of J-isobutyl-1-methylxanthine (IBMX) stimulated sulfated- 
proteoglycan biosynthesis after 20 h of incubation. CAMP had no significant effect. Both DBcAMP and 
8Br-CAMP increased the hydrodynamic size of the newly synthesized proteoglycan monomer (AlDl) 
relative to control cultures. By contrast, although isoproterenol and epinephrine stimulated total CAMP 
synthesis, neither stimulated sulfated-proteoglycan sy thesis. Whereas intracellular CAMP accumulated 
after incubation with DBcAMP and 8Br-CAMP, this was not the case with isoproterenol whether IBMX 
was present or not. Thus, stimulation of sulfated-proteoglycan synthesis by CAMP analogues in 
chondrocyte cultures appears to be dependent on increased intracellular CAMP accumulation rather than 
total CAMP biosynthesis. 
Cyclic AMP Chondrocyte Proteoglycan 
1. INTRODUCTION 
The role 3 ’ : 5 ‘-cyclic monophosphate (CAMP) 
plays in the metabolism of mammalian hyaline car- 
tilage remains undefined. In vitro incubation of 
embryonic cartilage, adult canine and foetal 
bovine cartilage as well as foetal rat and rabbit 
costal chondrocyte cultures with CAMP or CAMP 
derivatives has been shown to augment sulfated- 
proteoglycan synthesis [l-3], and hyaluronate syn- 
thesis [4]. Somatomedins, generally considered im- 
portant for the sulfation of glycosaminoglycans, 
either fail to stimulate adenylate cyclase [5] or may 
even inhibit adenylate cyclase activity in 
subcellular membranes of chondrocytes and car- 
tilage derived from chick embryos [a]. Adrenergic 
hormones epinephrine and isoproterenol have been 
shown to stimulate CAMP synthesis in cartilage 
and chondrocyte cultures [7,8]. In this study, 
Nd, d ’ -dibutyryladenosine 3 ’ : 5 ’ -cyclic mono- 
phosphate (DBcAMP), S-bromoadenosine 3’ : 5 ’ - 
cyclic monophosphate (8Br-CAMP), CAMP, L-iso- 
proterenol and L-epinephrine were compared with 
respect to sulfated-proteoglycan synthesis by rab- 
bit articular chondrocytes in monolayer culture. 
Here, we demonstrate that DBcAMP and 8Br- 
CAMP, but not CAMP itself significantly increased 
sulfated-proteoglycan synthesis. Stimulation of 
sulfated-proteoglycan synthesis was not achieved 
by incubation with isoproterenol or epinephrine, 
despite stimulation of chondrocyte CAMP syn- 
thesis by these hormones. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Monolayer cultures of rabbit articular chon- 
drocytes were established from pooled articular 
joints of the shoulder, knee and hip of immature 
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(1.5-2.0 kg) New Zealand albino rabbits as in [9]. 
After growth to confluency (7-10 days) in Ham’s 
F12 medium (Gibco, Grand Island, NY) contain- 
ing 10% foetal bovine serum (KC Biological, 
Lanexa, KA), penicillin-streptomycin (0.1 (r/o), 
fungizone (1 t70) and mycostatin (0.1 olo) (Gibco, 
Grand Island, NY), the cells were subpassaged by 
brief treatment with trypsin (15-20 min, 37°C). 
First passage cultures were established in 60 x 
15 mm tissue culture dishes (Falcon, Oxnard, CA) 
at an initial density of 3 x Id cells/dish in Dulbec- 
co’s Modi~ed Eagle’s medium (DM~M) (sulfate- 
free, MgCl2, 165 mgfml substituted for MgSGd; 
Gibco) containing 10% foetal bovine serum, 
penicillin-streptomycin, fungizone and mycostat- 
in, as above. After addition of serum and strepto- 
mycin sulfate, the total inorganic SO4 content of 
the medium was 12-13 mg/l [lo]. The cultures 
were maintained at 37°C in an atmosphere of 10% 
CO&W70 air. All experiments were conducted on 
sub-confluent cultures (3 days after establishment 
of first passage cultures). 
Chondrocyte cultures were incubated in DMEM 
containing 10% foetal bovine serum and sup- 
plements as above and each of several compounds, 
CAMP (1 mM), DBcAMP, sodium salt (1 mM), 
8Br-CAMP, sodium salt (1 mM) (Sigma, St. Louis, 
MO), or medium alone. Some cultures contained 
3-isobutyl-1-methylxanthine (IBMX) (100pM). 
Several control compounds were also utilized, 
sodium butyrate (1 mM) for DBcAMP, 
8Br-5 ’ -monophosphate (1 mM) for 8Br-CAMP, 
and guanosine 3 ’ : 5 ’ -cyclic monophosphate, 
sodium salt for cGMP, all 1 mM. Cell cultures 
were pre-incubated for 30 min with each com- 
pound. The cultures were washed with Gey’s BSS 
and then incubated in the absence or presence of 
each compound for 5 or 20 h containing Naz3’S0.+ 
(5 &i/ml) (New England Nuclear, Boston,’ MA, 
600-800 mCi/mmol). 
The medium and cells were separated. Medium 
was extracted by mixing a volume of medium with 
an equal volume of 8 M guanidine -HCl/O. 1 M 
sodium acetate (pH 5.8) containing 20 mM 
NazEDTA, 10 mM benzamidine, 0.1 mM 
6aminohexanoic acid and 10 mM phenylmethyl- 
sulfonyl fluoride. The cell layer was extracted with 
4 M guanidine~ HCUO.1 M sodium acetate (PH 
5.8) containing half the concentration of protein- 
ase inhibitors as above. Cell and medium 4 M gua- 
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nidine - HCl extracts were subjected to CsCl iso- 
pycnic density gradient ultra~ntrifugation under 
associative conditions fO.5 M guanidine .HCl/O. 1 
M sodium acetate (pH 5.8), Q,, = 1.60 g CsCl/ml] 
for 45 h at 1O’C (gaV = 81908). The bottom ‘/4 
fraction of the gradient tube (Al) was then sub- 
jected to a second gradient ultracentrifugation this 
time under dissociative conditions (4 M guani- 
dine- HCl/O. 1 M sodium acetate, e0 = 1 SO g 
CsCl/ml). The 2 most bottom fractions (AlDl and 
AlD2) were dialyzed against double-distilIed 
deionized water in dialysis membranes (Spec- 
trapor, Los Angeles, CA) with a molecular mass 
cutoff of 6 kDa. 
2.2. Measurement of 35SOd incorporation and gel 
filtration 
The retained 3’S04 was measured by liquid scin- 
tillation spectrometry in a Packard-Searle model 
3255 liquid scintillation system in Aquasol (New 
England Nuclear) using the ‘*C channel to detect 
“SO4. Counting efficiency was 75-80%. A por- 
tion of the dialyzed cellular and medium Al Dl and 
in some cases AlD2 fractions was applied to a col- 
umn of Sepharose CL-2B (0.8 x 118 cm) and 
eluted with 4 M guanidine. HCVO, 1 M sodium 
acetate (pH 5.8) [l 11, to obtain the average parti- 
tion coefficient (Kay) of the newly synthesized 
sulfated-proteoglycan monomer (AlDl) and other 
polydisperse 3sS04-containing proteoglycans 
(AlD2). 
2.3. Stimulation of CAMP synthesis and CAMP 
determination 
Sub-confluent chondroc~e monolayers were in- 
cubated for 30 min with either DBcAMP (1 mM), 
8Br-CAMP (1 mM), or L-isoproterenol (Sigma) or 
L-epinephrine (Sigma) (O-100 pM). The cultures 
were washed with GBSS and incubated for an ad- 
ditional O-20 h with or without the CAMP 
analogues, L-isoproterenol or L-epinephrine in 
medium with or without IBMX (1OOpM). Some 
cultures were incubated for the same period of 
time with 35SO~ (S&i/ml). In some of the 
isoproterenol experiments, cultures were co- 
incubated with isoproterenol and the &antagonist, 
DL-propr~olol (100 FM). Cultures incubated 
with 3”SOd were analyzed for “SO4 incorporation. 
Intracellular CAMP accumulation and CAMP 
secreted into the medium was measured by RIA 
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1121. DNA content/culture in DBcAMP, 8Br- 
CAMP, L-isoproterenol, L-epinephrine-treated 
and control cultures was measured by a modifica- 
tion of the diphenylamine technique 1131. 
Statistical analysis was performed by a two- 
tailed Student’s t-test to measure the significance 
of differences between the means of the sample 
groups. A p < 0.05 was taken as evidence of 
statistical significance. 
3. RESULTS 
3.1. Effect of CAMP, DBcAMP and 8Br-CAMP 
on proteoglycan synthesis 
DBcAMP and 8Br-CAMP stimulated 35S04 in- 
corporation after 20 h of incubation, but not after 
5 h. CAMP failed to increase 3”S04 incorporation 
(table 1). cGMP was without effect (not shown). 
DBcAMP and SBr-CAMP stimulated proteoglycan 
synthesis in the presence (table 1) or absence (table 
2) of IBMX, a phosphodiesterase inhibitor, and 
only if the CAMP analogues were in the medium 
during the 20 h labeling with 35S04 (table 1). 
Treatment of chondroc~es with either DBcAMP 
or 8Br-CAMP did not alter the DNA content of the 
cultures (control, 5.7 ag DNA/culture; DBcAMP, 
5.1; 8Br-CAMP, 5.5; CAMP, 6.3; sodium butyrate, 
5.1; 8Br-5’AMP, 5.7, average of 5 pooled cultures 
in each group). This result differs from previous 
work [ 131 which showed that maintenance of chon- 
drocytes in DBcAMP for up to 6 days was marked- 
ly cytotoxic. The shorter periods of exposure to the 
CAMP analogues used in the present study were 
not cytotoxic. In addition, the CAMP analogues 
altered slightly the partitioning of incorporated 
35S04 between the cellular-~ricell~l~ compart- 
ment and the medium into which the bulk of the 
proteoglycan was secreted (table 3). 
Table 1 
Effect of CAMP and cAMP analogues on 35S04 incorporation by chondrocytes 
Group Incubation time 
5h 20 h 
‘%04 35s04 
(cpm/culture X 10m5)’ @pm/culture x 10-5)a 
(+) (-) (+) (-) 
Control 4.14 + 0.20 - 9.09 + 0.44 
CAMP (1 mM) 4.41 * 0.06 4.09 f 0.20 11.04 f 0.90 7.79 f 0.14 
Sodium butyrate 
(1 mM) 4.18 f 0.05 3.93 f 0.09 7.71 + 0.26 7.71 f 0.55 
DBcAMP (1 mM) 4.47 * 0.12 4.08 f 0.09 14.12 f 1.23b 7.76 i 0.36 
8Br-5 ‘AMP 
(1 mM) 4.22 & 0.08 4.03 -t 0.24 8.92 f 0.27 7.92 f 0.24 
SBr-CAMP (1 mM) 4.41 f 0.09 4.03 f 0.24 16.71 f l.lSb 8.49 f 0.40 
a Mean & SD (n = 3) 
bp 6 0.05 
First passage articular chon~ocytes at sub-confluency (3 days after subculture) were 
preincubated for 30 min at 37°C with each of several compounds listed above and IBMX 
(1OOpM). Following this preincubation, cells were incubated in the absence (-) or 
presence (+ ) of these compounds together with 35S04 (5 &i/ml) for 5 or 20 h. Medium 
was extracted by mixing an equal volume of medium with 8 M guanidine*HCl/O.l M 
NaAc (pH 5.8) containing 2x proteinase inhibitors 1261 and dialyzed against deionized 
distilled Hz0 in membranes with a 6-8 kDa molecular mass cutoff at 4°C for 24 h. The 
retained 35S04 was counted by liquid s~intilIation spectrometry in Aquasol. Radioactivity 
was expressed as cpm/culture, since the DNA content of the cultures was not different 
at either 5 h or 20 h among the various groups 
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Table 2 
Effect of IBMX on D&AMP and 8Br-CAMP stimulation of proteoglycan synthesis 
Group IBMX 
WO/rM) 
35S04 (cpm/culture x lo-‘)” 
Cellular Medium Total 
Control - 1.49 f 0.04 6.86 f 0.47 8.35 f 0.50 
Control + 1.92 f 0.01 8.22 f 0.16 10.14 i 0.17b 
DBcAMP (1 mM) - 3.51 -I 0.20 10.52 1 0.30 14.03 f 0.48 
DBcAMP + 3.79 f 0.27 11.81 f 0.46 15.60 st 0.6sb 
SBr-CAMP (1 mM) - 2.54 rt. 0.02 8.99 f 0.04 11.54 f 0.04 
8Br-CAMP + 3.31 f 0.26 11.97 f 0.93 15.29 f 1.13b 
a Mean f SD (n = 3) 
bp < 0.05 (control, DBcAMP, 8Br-CAMP without IBMX compared to cultures 
containing IBMX) 
First passage articular chondrocytes at sub-confluency (3 days after subculture) 
were preincubated for 30 min at 37OC with either IBMX (lOOcM), DBcAMP or 
8Br-CAMP (1 mM) alone or in combination with IBMX. Following preincubation, 
the cells were incubated in the presence of DBcAMP or 8Br-CAMP with or without 
IBMX and 3sS04 for 20 h. 3sSO~ incorporation was measured as given in table 1 
Table 3 
Distribution of 35S04 in chondrocyte cultures treated with CAMP 
analogues 
Group 3sS04 (cpmfculture x lo-‘) 
Cellulara (Ore) Medium* (vo) 
Control 
Sodium butyrate 
(1 mM) 
DBcAMP (1 mM) 
8Br-5’AMP (1 mM) 
SBr-CAMP (1 mM) 
1.55 f 0.09 (15.1) 8.71 f 0.62 (84.9) 
1.20 f 0.08 (15.5) 6.51 f 0.31 (84.5) 
3.16 f 0.30 (22.4) 10.96 f 0.94 (77.6) 
1.43 * 0.05 (16.0) 7.49 f 0.23 (84.0) 
3.23 f 0.43 (19.3) 13.48 * 0.93 (80.7) 
a Mean f SD (n = 3) 
First passage chondrocyte cultures at sub-confluency were 
preincubated with various agents for 30 min at 37°C. Cultures were 
incubated with each agent including 35SG4 (5 &i/ml) for 20 h. 
Medium was separated from the cellular layer. The medium and cell 
layer were extracted separately with 4 M guanidine~HCl/O.l M 
sodium acetate containing proteinase inhibitors and dialyzed against 
deionized distilled Hz0 with 6-8 kDa molecular mass cutoff at 4°C 
for 24 h 
Neither DBoAMP nor 8Br-CAMP altered the 
percentage of 3sS04 in cellular or medium Al frac- 
tions or AlDl fractions (Al, medium, control, 
46.8%; DBcAMP, 50.3%, 8Br-CAMP, 50.2%; 
AlDl, cellular, control, 42.9%, DBcAMP, 
38.6%, 8Br-cAMP, 41.4%, AlDl, medium, con- 
trol, 53.4%, DBcAMP, 52.95%, 8Br-CAMP, 
57.6%). Chromatography of AlDl fractions on 
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Sepharose CL-2B eluted with 4 M guanidine- HCl 
(fig.1) revealed that both DBcAMP and 8Br- 
CAMP decreased the Kay of the larger of two pro- 
teoglycan species of rabbit articular cartilage 
[14-161. The smaller proteoglycan (Kav 0.80) 
eluting near the included volume of the column 
(IQ, and recently reported to be synthesized by ar- 
titular, but not epiphyseal chondrocytes [17] was 
unaffected by either DBcAMP or 8Br-CAMP in 
cellular and medium AlDl fractions. In addition, 
8BrcAMP shifted slightly the Kav of medium frac- 
tion AlD2 from 0.5 (control) to 0.42 (not shown). 
200 3.2. Effect of L-isoproterenol and L-epinephrine 
on proteoglycan synthesis 
L-Isoproterenol failed to stimulate proteoglycan 
synthesis. Over a wide range of concentrations 
(O-100 ,uM), isoproterenol failed to stimulate 
35S04 incorporation after 20 h incubation even 
when isoproterenol was present in the medium 
(fig.2). The DNA content (&g/culture) was not 
altered by L-isoproterenol from concentrations of 
50 
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Fig. 1. Sepharose CL3B chromatography elution 
profiles of 35S04-labeled proteoglycans in the AlDl 
fraction in cellular extracts and culture medium of 
control and DBcAMP or 8Br-CAMP-treated 
chondrocyte cultures. Sub-confluent cultures were 
labeled with Naz3’S04 (5 /rCi/ml for 20 h) as described 
in the text. Proteoglycans were extracted with 4 M 
guanidine - HCl/O. 1 M sodium acetate @H 5.8) 
containing proteinase inhibitors [26]. After dialysis, the 
radioactive material was freeze-dried, reconstituted in 
4 M guanidine * HCl/O. 1 M sodium acetate and layered 
onto the column. Column fractions of 0.9 ml were 
collected (flow rate = 10 ml/h). Recovery of 
radioactivity from the column averaged 98%. The 
vertical dotted line shows the Kav of untreated control 
cultures. V, is the void volume; vt is the total column 
volume: (A) cellular, (B) medium; (M) control, 
10 80 100 
l8OPROTERENOL o&4) 
Fig.2. Effect of isoproterenol on “SO4 incorporation by 
chondrocytes. Sub-confluent cultures were preincubated 
with varying concentrations of isoproterenol for 30 min 
at 37°C. Cultures were washed with GBSS and 
incubated in medium containing isoproterenol 
(O-100 /tM) and Na2%04 (5 pCi/ml for 20 h). Cellular 
and medium compartments were extracted with 4 M 
guanidine. HCl/O. 1 M sodium acetate as described in 
the text. Data are expressed as cpm/culture x 10m5. 
Below concentrations of SOpM, no difference in cell 
numbers or DNA content (Irg/culture) was measured. 
Control, 2.8 tg/culture; isoproterenol l-50 ,uM, 2.8, 
lOOtM, 0.6~~. Open area, total 3sS04 incorporation; 
hatched area, cellular 35S04 incorporation. Mean k SE, 
(bd) DBcAMP, (D-O) 8Br-CAMP. n = 3. 
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l-50pM (control, 2.8, lpM, 2.9, lOpM, 3.0, 
50pM, 2.8, average of 6 pooled cultures). The 
DNA content of cultures treated with 
isoproterenol (100 PM) was significantly dimin- 
ished (0.6 pg/culture). Thus, reduced incorpora- 
tion of ‘%04 at this concentration of isoproterenol 
was probably a result of cytotoxic effects of the 
hormone on the cells. 
The presence or absence of IBMX had no 
statistically significant effect on 35S04 incorpora- 
tion (control, 8.35 f O.SO/cpm per culture x lo-‘, 
control + IBMX, 10.14 f 0.17, isoproterenol, 
10m5 M, 8.28 f: 0.17, isoproterenol + IBMX, 9.95 
f 0.57, mean f SD, n = 3). The partitioning of 
35SOq between cellular and medium compartments 
was also unaffected (fig.2). 
Incubation with L-epinephrine (0- 100 ,uM) for 
20 h also failed to stimulate proteoglycan syn- 
thesis. No effect on DNA content/culture was seen 
at concentrations at or below 50/M. A cytotoxic 
appearance of the cells was frequently observed at 
a concentration of 100 PM (not shown). 35SO~ in- 
corporation was markedly inhibited at the higher 
epinephrine concentrations (100 ,uM). 
3.3. Effect of DBcAMP, 8Br-CAMP, 
isoproterenol and epinephrine on CAMP 
synthesis 
Immunoreactive CAMP accumulated within 
chondrocytes after treatment with DBcAMP and 
8Br-CAMP. The amount of intracellular im- 
munoreactive CAMP found was independent of the 
presence of IBMX (8Br-CAMP, 282.5 + 
57.6 pmol/culture; 8Br-CAMP + IBMX, 245.6 + 
45.0 mean f SE, n = 5) suggesting the relative 
resistance of these analogues to phosphodiesterase. 
Control culture immunoreactive CAMP was re- 
duced if IBMX was omitted (control 14.6 + 
2.0 pmol/culture; control + IBMX, 26.4 f 3.8). 
Treatment of chondrocytes with DBcAMP or 8Br- 
CAMP for 20 h increased cross-reacting in- 
tracellular CAMP levels (control, 44.4 + 13.8; 
DBcAMP, 2079 + 124.7, 8Br-CAMP, 410.6 & 
88.1 pmol/culture, mean f SE, n = 4). In- 
tracellular CAMP content measured just prior to 
addition of L-isoproterenol (zero time) was 
3 pmol/culture which increased to 6 pmol/culture 
after 0.5 h. Control cultures showed a smaller rise 
in intracellular CAMP in the first 0.5 h. However, 
isoproterenol failed to sustain intracellular CAMP 
levels over a 20 h period although the hormone did 
stimulate total CAMP synthesis (fig.3). Omission 
of IBMX reduced intracellular accumulation of 
CAMP in response to isoproterenol (isoproterenol, 
9.8 f 1.9; isoproterenol + IBMX, 16.5 + 5.7, 
mean + SE, n = 5). By 5 h, isoproterenol-stimul- 
ated CAMP synthesis was maximal, which stayed 
constant at 20 h. Epinephrine also failed to 
stimulate increased intracellular levels of CAMP, 
although total CAMP was increased. 
CELLULAR MEDIUM 
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Fig.3. Time course of L-isoproterenol stimulation of chondrocyte CAMP. Chondrocytes were incubated with 
isoproterenol (10pM) for the indicated time points. At each time point including zero time, cultures were terminated 
and intracellular and medium immunoreactive CAMP assayed as described in the text. (H) Control + IBMX, 
(+---o) isoproterenol + IBMX. 
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Fig.4. Effect of L-isoproterenol on CAMP and 
proteoglycan synthesis. Sub-confluent cultures were 
preincubated with varying concentrations of 
isoproterenol alone or isoproterenol and propranolol 
(100 FM) for 30 min at 37OC. Cultures were washed with 
GBSS and incubated as above in medium containing 
Na2%04 (5 &i/ml) and IBMX (100 ,uM) for 5 h. 
CAMP in cells and medium was measured by RIA. Total 
and cellular “SO4 incorporation was measured as 
described in the text. Differences in DNA content 
@g/culture) were not detected. (Top) 35S04 
incorporation, (bottom) CAMP (pmol/culture). (Open 
area) Total “SO4 incorporation or CAMP (cellular + 
medium); (hatched area) cellular 3sS04 or CAMP. 
Mean f SE, n = 3. 
3.4. Correlation of isoproterenol-stimulated 
CAMP and proteoglycan synthesis 
Despite stimulation of total CAMP synthesis 
(cells f medium), isoproterenol had no effect on 
sulfated-proteoglycan synthesis after 5 h (fig.4). 
Propranolol inhibited almost completely the 
isoproterenol-stimulation of CAMP. No effect on 
proteoglycan synthesis was seen in isoproterenol- 
propranolol co-incubates. 
4. DISCUSSION 
The present experiments have shown that 
DBcAMP and 8BrcAMP, agents which cause ac- 
cumulation of intracellular immunoreactive 
CAMP, stimulated proteoglycan synthesis by chon- 
drocytes. This result is similar to those in [l] with 
foetal rat chondrocyte monolayer cultures. In ad- 
dition, the CAMP analogues decreased the K,, of 
the newly synthesized proteoglycan subunit. This 
result differs from that obtained by authors in [2]. 
They reported that although DBcAMP stimulated 
glycosaminoglycan synthesis by foetal calf chon- 
drocytes, the size of the proteoglycan subunit was 
unaltered. This occurred despite a relative increase 
in chondroitin 4,6disulfate in DBcAMP-treated 
cultures. In the present study, synthesis of a small 
proteoglycan was unaffected by DBcAMP or 8Br- 
CAMP (fig. 1). Thus, the larger of two sulfated pro- 
teoglycan species found endogenously in rabbit 
cartilage [14] and synthesized by cartilage organ- 
explants and chondrocytes [15,161 was specifically 
affected by treatment with CAMP analogues. The 
K,, of the larger proteoglycan species was, 
however, larger (0.45) than that found in the AlDl 
fraction of chondrocytes grown to high density 
and containing multiple dense chondroid nodules 
[16]. 8Br-CAMP increased the hydrodynamic size 
of sub-confluent chondrocyte newly synthesized 
AlDl proteoglycan to that comparable to multi- 
layered chondrocyte cultures. Isoproterenol and 
epinephrine, which stimulated total CAMP syn- 
thesis, failed to cause intracellular accumulation of 
CAMP and did not stimulate proteoglycan 
synthesis. 
The effect of 8Br-CAMP and DBcAMP on 
quantitative proteoglycan synthesis were 
equivalent despite reports that 8Br-CAMP is more 
resistant to phosphodiesterases than DBcAMP 
[18]. In addition, 8Br-CAMP unlike DBcAMP has 
been shown to bind to protein kinase without in- 
tracellular conversion to an active form. When 
IBMX was excluded from the medium in the 
presence of 8Br-CAMP or DBcAMP, ‘5S04 incor- 
poration was reduced. It is uncertain, however, as 
to how much of the CAMP measured intracellular- 
ly is newly synthesized CAMP and how much 
represents the CAMP analogues which cross-react 
with the CAMP antibody in the RIA. Approx. 
0.006% of the added DBcAMP was found as 
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either CAMP or cross-reacting DBcAMP in the cell 
compartment after 1 h. Under basal conditions (no 
stimulus), however, total CAMP synthesis was 
greatly reduced if IBMX was excluded and a 
greater proportion of the CAMP was found ex- 
truded into the. medium. Other agents able to 
stimulate CAMP synthesis in chondrocyte cultures 
(PGE2, A23 187) resulted in intracellular accumula- 
tion of CAMP [la]. A23187 which stimulated 
CAMP 6-fold in 7 rnin caused marked extrusion of 
CAMP into the medium as well. Despite the 
presence of IBMX in the medium of isoproterenol 
and epinephrine-stimulated chondrocyte cultures, 
CAMP failed to accumulate intracellul~ly, A 
greater amount of CAMP was found in the medium 
than in control cultures. This release of CAMP into 
the medium could have come about by a failure of 
intracellular CAMP to bind to a protein kinase 
receptor which may increase the secretion of newly 
synthesized intracellular CAMP into the medium. 
Stimulation of proteoglycan synthesis by ac- 
cum~ation of intra~llul~ CAMP is likely related 
to the known stimulatory effects of CAMP on 
amino acid transport [19], and total protein and 
RNA synthesis [20]. Proteoglycan synthesis has 
been correlated with increased amino acid 
transport [21] and the Gr phase of the cell cycle 
where transport of amino acid analogues is 
thought to be maximal 11,221. In addition, in- 
tracellular ac~mulation of CAMP may be respon- 
sible for the phosphorylation of newly synthesized 
proteoglycan, in cartilage [23] and chondrosar- 
coma cultures [24], An increase in RNA synthesis 
is coordinate with CAMP accumulation and the 
stimulation of poly(A) RNA synthesis occurs by 
direct nuclear effects of specific cyclic 
AMP-cytosolic CAMP binding protein complex 
(251. The phosphorylation of proteoglycan may 
play a role in the level of synthesis and the total of 
newly synthesized proteoglycan secreted into the 
culture medium. The finding that DBcAMP and 
8Br-CAMP stimulation occurred only if it was pre- 
sent in the medium during the entire 20 h labeling 
with “SO4 suggested that sustained formation of 
CAMP-protein kinase complexes is required for 
maximal sedation of proteoglycan by CAMP in 
chondrocyte monolayer cultures. 
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